Member Info for Brighty1

The 50,000 buyer is back again.

19-Nov-20 13:57:39 55.50 50,000 Buy* 55.00 55.50 27.75k

Plus here's the last 2 days big buys. Getting more and more interesting. Follow the money... Good luck, Brighty

18-Nov-20 16:06:22 52.76 27,004 Buy* 52.00 53.00 14.25k O
18-Nov-20 16:05:44 52.76 26,961 Buy* 52.00 53.00 14.22k O
18-Nov-20 16:02:02 53.20 30,000 Buy* 52.00 53.00 15.96k O
18-Nov-20 16:00:32 52.71 27,255 Buy* 52.00 53.00 14.37k O
18-Nov-20 15:41:34 53.00 35,000 Buy* 52.00 53.00 18.55k O
18-Nov-20 15:39:59 52.61 25,000 Buy* 52.00 53.00 13.15k O
18-Nov-20 15:33:31 52.94 39,648 Buy* 52.00 53.00 20.99k O
18-Nov-20 15:30:10 53.335 24,000 Buy* 52.00 53.00 12.80k O
18-Nov-20 16:20:55 52.60 13,307 Buy* 52.00 53.00 6,999 O
17-Nov-20 09:50:53 56.20 40,000 Buy* 52.00 53.00 22.48k O
17-Nov-20 12:08:45 55.35001 99,334 Buy* 52.00 53.00 54.98k O
17-Nov-20 08:22:17 57.4212 45,000 Buy* 52.00 53.00 25.84k O
17-Nov-20 09:58:49 56.15001 45,380 Buy* 52.00 53.00 25.48k O
17-Nov-20 08:33:04 57.74999 40,000 Buy* 52.00 53.00 23.10k O
17-Nov-20 16:19:52 54.97 89,115 Buy* 52.00 53.00 48.99k O
17-Nov-20 08:27:56 56.1501 56,815 Buy* 52.00 53.00 31.90k O
17-Nov-20 15:02:52 55.34999 50,000 Buy* 52.00 53.00 27.67k O
17-Nov-20 12:36:51 54.25001 70,461 Buy* 52.00 53.00 38.23k O
17-Nov-20 16:20:12 53.1501 69,664 Buy* 52.00 53.00 37.03k O
17-Nov-20 13:10:03 53.02 74,757 Buy* 52.00 53.00 39.64k O
17-Nov-20 12:02:51 55.35001 73,769 Buy* 52.00 53.00 40.83k O
17-Nov-20 08:04:54 62.25 49,088 Buy* 52.00 53.00 30.56k O
17-Nov-20 08:36:42 59.4549 69,000 Buy* 52.00 53.00 41.02k O
17-Nov-20 11:59:53 56.2001 40,098 Buy* 52.00 53.00 22.54k O
17-Nov-20 08:04:57 62.0018 104,580 Buy* 52.00 53.00 64.84k O
17-Nov-20 16:03:05 54.20 46,824 Buy* 52.00 53.00 25.38k O
17-Nov-20 08:10:29 60.00 50,000 Buy* 52.00 53.00 30.00k O
17-Nov-20 08:47:32 57.20 69,217 Buy* 52.00 53.00 39.59k O
17-Nov-20 08:05:27 63.75 59,217 Buy* 52.00 53.00 37.75k O
17-Nov-20 08:19:59 57.65001 40,000 Buy* 52.00 53.00 23.06k O
17-Nov-20 09:22:15 55.25001 79,114 Buy* 52.00 53.00 43.71k O
17-Nov-20 15:54:23 55.74999 39,750 Buy* 52.00 53.00 22.16k O
17-Nov-20 10:40:39 56.20 44,459 Buy* 52.00 53.00 24.99k O
17-Nov-20 08:24:03 57.80 51,894 Buy* 52.00 53.00 29.99k O
17-Nov-20 08:07:38 60.2002 66,536 Buy* 52.00 53.00 40.05k O
17-Nov-20 08:06:43 62.40 50,000 Buy* 52.00 53.00 31.20k O
17-Nov-20 12:36:26 54.5001 45,872 Buy* 52.00 53.00 25.00k

I am of the opinion that once the OO is out of the way & dividends are reinstated that the share price fortunes of Bwng will improve on the back of the boom in online shopping. I reckon that is also what is driving Lord and Joshua Alliance to underwrite the OO. Share prices do have monumental bounce backs. See Taylor Wimpey a few years back (11p to 200p). It's certainly possible. Dyor but a reminder that this was trading between 200p - 350p when the dividend was being paid. It was still trading at over 150p when the dividend was reduced by 50%, pre Covid, in January of this year. Best of luck Bwng investors, Brighty

RMM, I would suggest that Numis would be a much better fit for Sareum than the current incumbent. Pharma peers such as SNG and NCYT are with Numis for example. Say no more. Regarding public relations, in the ten years I have been an investor in Sareum it has been their biggest achilles heel. Great science should equate to lots to shout about. They need to get this sorted. Good luck, Brighty

Huge confidence in ODX being shown with these buys. Follow the money. Good luck, Brighty.
18-Nov-20 16:06:22 52.76 27,004 Buy* 52.00 53.00 14.25k O
18-Nov-20 16:05:44 52.76 26,961 Buy* 52.00 53.00 14.22k O
18-Nov-20 16:02:02 53.20 30,000 Buy* 52.00 53.00 15.96k O
18-Nov-20 16:00:32 52.71 27,255 Buy* 52.00 53.00 14.37k O
18-Nov-20 15:41:34 53.00 35,000 Buy* 52.00 53.00 18.55k O
18-Nov-20 15:39:59 52.61 25,000 Buy* 52.00 53.00 13.15k O
18-Nov-20 15:33:31 52.94 39,648 Buy* 52.00 53.00 20.99k O
18-Nov-20 15:30:10 53.335 24,000 Buy* 52.00 53.00 12.80k O
18-Nov-20 16:20:55 52.60 13,307 Buy* 52.00 53.00 6,999 O
18-Nov-20 16:16:16 51.94 19,245 Sell* 52.00 53.00 9,996 O
17-Nov-20 09:50:53 56.20 40,000 Buy* 52.00 53.00 22.48k O
17-Nov-20 12:08:45 55.35001 99,334 Buy* 52.00 53.00 54.98k O
17-Nov-20 08:22:17 57.4212 45,000 Buy* 52.00 53.00 25.84k O
17-Nov-20 09:58:49 56.15001 45,380 Buy* 52.00 53.00 25.48k O
17-Nov-20 08:33:04 57.74999 40,000 Buy* 52.00 53.00 23.10k O
17-Nov-20 16:19:52 54.97 89,115 Buy* 52.00 53.00 48.99k O
17-Nov-20 08:27:56 56.1501 56,815 Buy* 52.00 53.00 31.90k O
17-Nov-20 15:02:52 55.34999 50,000 Buy* 52.00 53.00 27.67k O
17-Nov-20 12:36:51 54.25001 70,461 Buy* 52.00 53.00 38.23k O
17-Nov-20 16:20:12 53.1501 69,664 Buy* 52.00 53.00 37.03k O
17-Nov-20 13:10:03 53.02 74,757 Buy* 52.00 53.00 39.64k O
17-Nov-20 12:02:51 55.35001 73,769 Buy* 52.00 53.00 40.83k O
17-Nov-20 08:04:54 62.25 49,088 Buy* 52.00 53.00 30.56k O
17-Nov-20 08:36:42 59.4549 69,000 Buy* 52.00 53.00 41.02k O
17-Nov-20 11:59:53 56.2001 40,098 Buy* 52.00 53.00 22.54k O
17-Nov-20 08:04:57 62.0018 104,580 Buy* 52.00 53.00 64.84k O
17-Nov-20 16:03:05 54.20 46,824 Buy* 52.00 53.00 25.38k O
17-Nov-20 08:10:29 60.00 50,000 Buy* 52.00 53.00 30.00k O
17-Nov-20 08:47:32 57.20 69,217 Buy* 52.00 53.00 39.59k O
17-Nov-20 08:05:27 63.75 59,217 Buy* 52.00 53.00 37.75k O
17-Nov-20 08:19:59 57.65001 40,000 Buy* 52.00 53.00 23.06k O
17-Nov-20 09:22:15 55.25001 79,114 Buy* 52.00 53.00 43.71k O
17-Nov-20 15:54:23 55.74999 39,750 Buy* 52.00 53.00 22.16k O
17-Nov-20 10:40:39 56.20 44,459 Buy* 52.00 53.00 24.99k O
17-Nov-20 08:24:03 57.80 51,894 Buy* 52.00 53.00 29.99k O
17-Nov-20 08:07:38 60.2002 66,536 Buy* 52.00 53.00 40.05k O
17-Nov-20 08:06:43 62.40 50,000 Buy* 52.00 53.00 31.20k O
17-Nov-20 12:36:26 54.5001 45,872 Buy* 52.00 53.00 25.00k

You are invested in an amazing life saving business. Check out the ShareSoc Webinar with Synairgen's ceo tonight between 5-6pm for reassurance. Dyor but SNG001 boosts lung defences. So it will stop Coronavirus and Influenza attacking and damaging the lungs. That means in the pharma sector a takeover or Licencing deal is a real possibility. SNG has demonstrated that it can save lives. Good luck, Brighty

Our NED Dr Mike Owen is Chairman of Avacta’s scientific advisory board. AVCT have had an amazing year up from 13p to a high of 215p (& up 20% today) Looks like Dr Owen is bringing his magic to Sareum.....Good luck all Sareum investors, Brighty

Beautifully and succinctly articulated Zwartkops and Dudio. You've nailed it. Well said. Good luck to all SNG investors, Brighty

Research has proven that SNG001 boosts lung defences, so not only are we going to be halting Coronavirus attacking and damaging the lungs but SNG001 also stops influenza in its tracks. In the real world this = Takeover or Licencing. Ignore the negativity is my advice. SNG has demonstrated that it can save lives. i.e. patients who had SNG001 were more than twice as likely to recover & there were no deaths in the group taking the SNG drug. This is one of the most exciting and promising stocks to be invested in over the coming year or two. Good luck, Brighty

The Lancet is a far better read for the inside track. You don't then get sucked in to "agenda" media. i.e. Just the facts and research. That's the way to cut through the hype. ODX is on the cusp of substantial share price gains if you do the sums re sales projections moving forward. Good luck, Brighty

Could be as The Lancet makes for interesting reading today in relation to that point. FLT perhaps? Summary of the article below. Good luck, Brighty

CoronaVac (Sinovac Life Sciences, Beijing, China) is an inactivated vaccine candidate against COVID-19 that has shown good immunogenicity in mice, rats, and non-human primates with vaccine-induced neutralising antibodies to SARS-CoV-2, which could neutralise ten representative strains of SARS-CoV-2.
15
Moreover, the results indicated CoronaVac provided partial or complete protection in macaques from severe interstitial pneumonia after a SARS-CoV-2 challenge, without observable antibody-dependent enhancement of infection.
Interpretation: Taking safety, immunogenicity, and production capacity into account, the 3 µg dose of CoronaVac is the suggested dose for efficacy assessment in future phase 3 trials.

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30843-4/fulltext

Yes, agreed. I've been here since buying in to SNG at 29p. Huge global potential with evidence patients taking SNG001 are more than twice as likely to recover & there were NO deaths in the group taking the SNG drug formulation as well as research indicating that our invention boosts lung defences, so it's a win win not just against Covid but also to stop influenza taking hold in the lungs. Good luck all SNG investors, Brighty

The ‘positive’ vaccine news does not phase me from an investment perspective. Synairgen has proved conclusively that Inhaled interferon can save lives and consequently Synairgen is the real deal in my opinion. We already have been informed via an RNS that patients who had SNG001 were more than twice as likely to recover & there were no deaths in the group taking the SNG drug formulation. What's even more commercially astounding for all SNG shareholders is that the research is proving that our invention boosts lung defences, so it's a win win not just for Coronavirus but to halt influenza etc. Once people realise what SNG is all about the share price will rise. The Lancet got it right about SNG the other day and let’s face it they are the experts re the science compared to the MM’s. I’m suggesting £8 - £10 in due course. Good luck, Brighty

Between 2017 and 2019 when dividends were being paid we were trading in the 250p to 350p share range. At the start of this year - before the Covid pandemic - the share price was over 150p (& that was with a dividend reduction of 50% and much larger debt). Exciting times for those looking for gains over the next 12 months. Good luck, Brighty

I concur with you. The RNS’ of late have afforded considerable clarity to a potential suitor from an M&A (or licencing) standpoint. In the course of any due diligence Sareum would have to be granting the suitor (be it a trade sale or licencing deal) indemnification obligations plus apprising them of any unresolved milestone, licencing & patent issues. I’ve been saying for a while now that Sareum is getting all their ducks in a row. The 737 RNS issued last week, the Covid RNS 2 weeks ago and the patent RNS last month certainly support this position. i.e.Thoth's 28p+ party is slowly and surely becoming a reality. Good luck, Brighty

Whilst we await our next news and further to my regular dispatches here on the magnificent share price rises in the pharmaceutical sector by peers such as Sng, Ncyt, Odx, Hemo, Avct, Pyc, Ygen, N4P, Val etc I am also adding RMS as an example of what could quite easily materialise with Sareum’s share price soon. RMS is up from 0.22p in July to a high of 7.15p today. RMS did a Sareum style rise from 0.3 to over 1p between July and October. RMS then went up to 2.20p on October 27th, then up to 4.45p on November2nd with a temporary drop to 1.20p on 10th November before climbing over the last few days to 7.15p today. It’s a fascinating example of a similar share price to that of Sareum over the last year. i.e. The share price of both co’s have been relatively parallel, until very recently. It is consequently a practical share price pattern to emphasise. I’m advocating that once the next piece of positive Sareum news arrives we will hopefully undergo something similar. This would also not be dissimilar to what has transpired over at Hemo, up from 1p to 15p. This is the short term picture. I'm with the 28p + share price brigade long term. Very best of luck to all Sareum investors, Brighty

Thanks. Yes, I have been hopeful for a while that Merck is the one for us. The implications would be stratospheric for Sareum's share price. Having said that, Gilead or any of the majors would be great news but MSD appear to me to be a perfect global fit for taking 737 forward. Good luck, Brighty

The stunning statistic that interests me the most is that according to the recent RNS Omega will manufacture not less than 25% of the demand from total orders placed, either from the UK Government or third party customers. Once people cotton on to the magnitude of how much profit ODX is going to be making the share price really is going to take off. Good luck, Brighty

People have not been dong the maths here over the last few days. The drop in the share price was daft. As I keep flagging up, the revenue stream for ODX could be huge. Atonishing gains potentially to be made here. Testing is not going anywhere for a long time. Follow the money. Good luck, Brighty

Just a quick footnote to Stoney's very informative reminder about SRA 737. It is also worth noting that gemcitabine has been studied as a treatment for kaposi sarcoma, a common cancer in people with AIDS. i.e. huge potential global revenue streams from this. All in all it looks as though, at last, the monetization of 737 is about to commence. The impact for Sareum shareholders as a result could be a mind boggling return on our investment moving forward. Good luck, Brighty

Nick, 100% agreement with you plus they were also very well organised re contacting key journalists. They would target Robert Peston at ITV, Fergus Walsh at BBC News, Ian King and Thomas Moore at Sky News plus all the national newspapers such as Daily Mail, Times, Guardian, Telegraph, Express, Independent plus CNN and Huff Post etc about NCYT with the information they had found out about. Can you imagine if this was replicated here in a concerted and coordinated way with the UK media about Sareum. There is so much news about Sareum's science that would be of interest to the relevant national journalists. Just look at the last year on this forum. So many discoveries by well informed posters. Imagine if this had been communicated to key journalists. I have voiced this before but I do wonder if the PR incumbents, Citigate, are up to the challenge. So far I have not been impressed at all when you measure our awareness with our peers. In many cases we have had much more interesting news to share but all we appear to do is appear in the local Cambridge newspaper or not at all. The NCYT share holder group has been awesome at this in particular and SNG's PR has been simply fantastic (today being another example). Good luck, Brighty